Caplin Point Laboratories Financial Results
- Market cap
- ₹20,331 crore
- P/E
- 30.6
- P/B
- 5.67
- ROE
- 19.9%
- Dividend yield
- 0.15%
For the year ended Mar 2020, Caplin Point Laboratories reported revenue of ₹863 crore and net profit of ₹215 crore, against ₹1,061 crore and ₹251 crore a year earlier.
Caplin Point Laboratories annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Revenue | 863 | 1,061 | — | 1,454 | 1,680 | 1,921 | 2,171 | 2,272 |
| Expenses | 603 | 733 | — | 1,010 | 1,128 | 1,268 | 1,404 | 1,468 |
| Operating profit | 260 | 329 | — | 443 | 551 | 653 | 767 | 803 |
| Operating margin % | 30% | 31% | — | 30% | 33% | 34% | 35% | 35% |
| Other income | 41 | 24 | — | 54 | 67 | 90 | 109 | 119 |
| Interest | 0 | 2 | — | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 32 | 37 | — | 45 | 53 | 66 | 73 | 78 |
| Profit before tax | 269 | 314 | — | 451 | 564 | 677 | 803 | 844 |
| Tax % | 20% | 20% | — | 16% | 18% | 20% | 19% | 20% |
| Net profit | 215 | 251 | — | 377 | 461 | 541 | 650 | 678 |
| EPS (₹) | 28.33 | 31.92 | — | 49.57 | 60.19 | 70.56 | 84.36 | 87.53 |
| Dividend payout % | — | — | — | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Caplin Point Laboratories financial results — frequently asked questions
What is Caplin Point Laboratories' annual revenue and net profit?
For the financial year ended Mar 2020, Caplin Point Laboratories' revenue was ₹863 crore and net profit ₹215 crore; net profit fell 14.34% from ₹251 crore in Mar 2021.
How fast has Caplin Point Laboratories grown over three years?
From Mar 2023 to Mar 2020, Caplin Point Laboratories' revenue grew at a compound annual rate of -16.0% and net profit at -17.1%. Past growth does not indicate future results.
What is the EPS of Caplin Point Laboratories?
Annual EPS for Mar 2020 was ₹28.33.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Caplin Point Laboratories With ATS
Track CAPLIPOINT live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.